CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit,
K-Number: K181736 · 2018-07-30
Device Summary
Frequently Asked Questions
What is the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit,?
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit, is a medical device that received FDA 510(k) clearance on 2018-07-30. It is manufactured by Centers For Disease Control and Prevention (CDC). The 510(k) number is K181736.
When was CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit, approved by the FDA?
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit, received FDA 510(k) clearance on 2018-07-30, under approval number K181736.
What company makes CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit,?
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit, is manufactured by Centers For Disease Control and Prevention (CDC).
What is the FDA product code for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit,?
The FDA product code for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit, is OZE.
Related Clinical Trials
Related PubMed Literature
Other Devices by Centers For Disease Control and Prevention (CDC)
Related Devices (Code: OZE)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.